{
    "organizations": [],
    "uuid": "170a674b138fb0c6b551f23a1de94b6fb917a6dc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eli-lilly-to-acquire-aurka-pharma/brief-eli-lilly-to-acquire-aurka-pharma-idUSASC0A1X3",
    "ord_in_thread": 0,
    "title": "BRIEF-Eli Lilly To Acquire Aurka Pharma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - Eli Lilly and Co:\n* LILLY WILL ACQUIRE ALL SHARES OF AURKA PHARMA * AURKA PHARMA SHAREHOLDERS WILL RECEIVE AN UPFRONT PAYMENT OF $110 MILLION\n* AURKA PHARMA SHAREHOLDERS ARE ALSO ELIGIBLE TO RECEIVE UP TO $465 MILLION IN REGULATORY AND SALES MILESTONES\n* THERE WILL BE NO CHANGE TO LILLY’S 2018 NON-GAAP EARNINGS PER SHARE GUIDANCE AS A RESULT OF DEAL\n* FY2018 EARNINGS PER SHARE VIEW $5.15 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-14T20:07:00.000+03:00",
    "crawled": "2018-05-15T14:15:39.033+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eli",
        "lilly",
        "co",
        "lilly",
        "acquire",
        "share",
        "aurka",
        "pharma",
        "aurka",
        "pharma",
        "shareholder",
        "receive",
        "upfront",
        "payment",
        "million",
        "aurka",
        "pharma",
        "shareholder",
        "also",
        "eligible",
        "receive",
        "million",
        "regulatory",
        "sale",
        "milestone",
        "change",
        "lilly",
        "earnings",
        "per",
        "share",
        "guidance",
        "result",
        "deal",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}